ENO Robert Paul 4

What Happened
Robert Paul, President of HeartBeam, received a grant of stock options covering 55,172 shares on February 9, 2026. The reported acquisition price is $0.00 (derivative award, transaction code "A"). These options were issued under the company's 2022 Equity Incentive Plan and were recorded on a Form 4 filed March 23, 2026.

Key Details

• Transaction date: February 9, 2026 (Form 4 filed March 23, 2026 — filing was late).
• Transaction type/code: Grant/Award (derivative securities), coded "A".
• Shares/options granted: 55,172 underlying shares. Reported acquisition price: $0.00.
• Vesting: Per filing footnote — one-half of the Shares vest on March 31, 2026 (three-month anniversary of a Jan 1, 2026 vesting commencement), and the remaining half vest on June 30, 2026 (six-month anniversary).
• Plan: Issued under the Company’s 2022 Equity Incentive Plan.
• Shares owned after transaction: Not stated in the provided filing data.
• Strike/exercise price and other economic terms: Not disclosed in the summary provided.
• Timeliness: Marked late (transaction occurred Feb 9; Form 4 filed Mar 23). Late filing can draw SEC attention or penalties but does not by itself imply misconduct.

Context
This was an option grant (an award), not a cash purchase or sale. Options vest over a short schedule (March 31 and June 30, 2026), meaning the recipient must stay employed/meet conditions to realize any value. Because the exercise/strike price and market price at vesting are not shown here, the immediate dollar value of the grant isn’t specified in the filing. Grants align executives’ incentives with shareholders over the vesting period but should not be interpreted alone as a buy/sell signal.